Ping Li1,2, Kang Chen1, Yi Nie1, Ling-Ling Guo1,3, Hai-Bin Wang1, Shuang-Shuang Wang1, An-Ping Wang1, Da-Yi Hu4, Yi-Ming Mu1, Ji-Hu Li5. 1. a a Department of Endocrinology , Chinese PLA General Hospital , Beijing , China. 2. b b Department of Endocrinology , Hebei General Hospital , Shijiazhuang , China. 3. c c Department of Endocrinology , Beijing Electric Power Hospital , Beijing , China. 4. d d Department of Cardiology , Peking University People's Hospital , Beijing , China. 5. e e MSD China Holding Co. Ltd , Shanghai , China.
Abstract
OBJECTIVE: To investigate the associations between obesity and any significant improvements in glycemic control, blood pressure, and lipid targets in Chinese patients with concomitant type 2 diabetes mellitus (T2DM) and hypertension. METHODS AND RESULTS: A total of 3041 dyslipidemia patients with an average age of 65.7 ± 10.53 years and comorbid conditions of T2DM and hypertension from the DYSlipidemia International Study (DYSIS) - China were included in the present subgroup analysis. Patients' demographic data, medication use, blood glucose, and lipid parameters were analyzed retrospectively. Body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WtHR) differed significantly among participants according to the attainment of treatment targets. Among female patients, significant differences in the rate of target attainment were observed among different WC, WtHR, and BMI quartile groups, whereas no significant differences in goal attainment were found according to WC and WtHR quartiles in male patients. Among the female patients, the results of logistic regression supported a significant association of anthropometric indices and the achievement of targets. CONCLUSION: A considerable proportion of dyslipidemia patients failed to achieve guideline-recommended targets in China, and this apparent treatment gap was more pronounced among women with central adiposity and patients with an elevated BMI. Based on the limitations of this cross-sectional study, further investigation of the mechanism at the molecular level is necessary.
OBJECTIVE: To investigate the associations between obesity and any significant improvements in glycemic control, blood pressure, and lipid targets in Chinese patients with concomitant type 2 diabetes mellitus (T2DM) and hypertension. METHODS AND RESULTS: A total of 3041 dyslipidemiapatients with an average age of 65.7 ± 10.53 years and comorbid conditions of T2DM and hypertension from the DYSlipidemia International Study (DYSIS) - China were included in the present subgroup analysis. Patients' demographic data, medication use, blood glucose, and lipid parameters were analyzed retrospectively. Body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WtHR) differed significantly among participants according to the attainment of treatment targets. Among female patients, significant differences in the rate of target attainment were observed among different WC, WtHR, and BMI quartile groups, whereas no significant differences in goal attainment were found according to WC and WtHR quartiles in male patients. Among the female patients, the results of logistic regression supported a significant association of anthropometric indices and the achievement of targets. CONCLUSION: A considerable proportion of dyslipidemiapatients failed to achieve guideline-recommended targets in China, and this apparent treatment gap was more pronounced among women with central adiposity and patients with an elevated BMI. Based on the limitations of this cross-sectional study, further investigation of the mechanism at the molecular level is necessary.
Authors: L Masmiquel; L A Leiter; J Vidal; S Bain; J Petrie; E Franek; I Raz; A Comlekci; S Jacob; L van Gaal; F M M Baeres; S P Marso; M Eriksson Journal: Cardiovasc Diabetol Date: 2016-02-10 Impact factor: 9.951